556025-47-9

Basic information

• Product Name: N-(4-chlorobenzyl)-9-(chloromethyl)-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide
• Synonyms: N-(4-chlorobenzyl)-9-(chloromethyl)-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide
• CAS NO: 556025-47-9
• Molecular Weight: 430.29
• Mol File: 556025-47-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(4-chlorobenzyl)-9-(chloromethyl)-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-chlorobenzyl)-9-(chloromethyl)-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide(556025-47-9)
• EPA Substance Registry System: N-(4-chlorobenzyl)-9-(chloromethyl)-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide(556025-47-9)

Safety Data

• Hazardous Substances Data: 556025-47-9(Hazardous Substances Data)

Upstream product

• 552883-98-4 N-(4-chlorobenzyl)-1-methyl-9-(morpholin-4-ylmethyl)-2,7-dioxo-2,3-dihydro-1H,7H-pyrido [1,2,3-de]quinoxaline-6-carboxamide 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 1224582-43-7 C₂₈H₂₇ClN₄O₅ 
• 556025-29-7 N-(4-chlorobenzyl)-9-{[[(2R)-2-hydroxy-2-(1,3-thiazol-2-yl)ethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 
• 1224582-45-9 C₂₇H₂₆ClN₅O₄S 
• 556025-20-8 N-(4-chlorobenzyl)-9-{[[(2S)-2-hydroxy-2-pyridin-3-ylethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 
• 1224582-41-5 C₂₉H₂₈ClN₅O₄ 
• 556025-21-9 N-(4-chlorobenzyl)-9-{[[(2S)-2-hydroxy-2-thien-3-ylethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 
• 1224582-44-8 C₂₈H₂₇ClN₄O₄S 
• 556025-28-6 N-(4-chlorobenzyl)-9-{[[(2R)-2-hydroxy-2-pyrazin-2-ylethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 
• 1224582-42-6 C₂₈H₂₇ClN₆O₄ 
• 556025-16-2 N-(4-chlorobenzyl)-9-{[[(2R)-2-hydroxy-2-pyridin-2-ylethyl](methyl)amino]methyl}-1-methyl-2,7-dioxo-2,3-dihydro-1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamide 
• 1224582-40-4 C₂₉H₂₈ClN₅O₄ 
• 556025-22-0 C₃₂H₂₉ClN₄O₄S 
• 556025-10-6 C₃₂H₂₉ClN₄O₅ 
• 1224582-39-1 C₃₀H₂₉ClN₄O₄ 

Relevant articles and documents

The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase

Discovery efforts were focused on identifying a non-nucleoside antiviral for treating infections caused by human cytomegalovirus (HCMV) with equal or better potency and diminished toxicity compared to current therapeutics. This Letter describes the HCMV D